Fatal pulmonary embolism due to ınherited thrombophilia factors in a child with wolfram syndrome

Autor: Kucuktasci, K., Semiz, Serap, Balcı, Yasemin Işık, Özsari, T., Gürses, Dolunay, Önem, Gökhan, Saçar, Mustafa, Düzcan, Füsun, Yüksel, Doğangün, Semiz, Ender
Jazyk: angličtina
Rok vydání: 2016
Předmět:
desmopressin
pulmonary embolism
loading drug dose
resuscitation
heparin
thrombofilia risk factors
physical examination
protein C
rheumatoid factor
computer assisted tomography
diabetic ketoacidosis
Fatal Outcome
methylenetetrahydrofolate reductase gene
echocardiography
Thrombophilia
genetics
gene mutation
C reactive protein
heart atrium thrombosis
single drug dose
enoxaparin
optic nerve atrophy
blood clotting factor 5
female
priority journal
risk factor
diabetes insipidus
thrombectomy
laboratory test
diabetes mellitus
activated protein C resistance
lung embolism
insulin
cardiopulmonary arrest
Adolescent
methylenetetrahydrofolate reductase (NADPH2)
complication
embolism
insulin dependent diabetes mellitus
Article
clinical examination
fatality
case report
degenerative disease
heterozygosity
Humans
human
gene
thrombosis
Wolfram syndrome
Glasgow coma scale
Factor V
hearing impairment
thromboembolism
ceftriaxone
warfarin
blood clotting factor 5 Leiden
Diabetes Mellitus
Type 1

homozygosity
Popis: Wolfram syndrome-1 is a rare and severe autosomal recessive neurodegenerative disease characterized by diabetes mellitus (DM), optic atrophy, diabetes insipidus, and deafness. Poorly controlled type 1 DM increases the risk for thrombosis. However, coexistence of DM and hereditary thrombosis factors is rarely observed. Here we present the case of a 13.5-year-old, nonfollowed girl newly diagnosed with poorly controlled Wolfram syndrome on the basis of the results of clinical and laboratory examinations. On the eighth day after diabetic ketoacidosis treatment, pulmonary embolism developed in the subject. Thrombus identified in the right atrium using echocardiography was treated by emergency thrombectomy. Homozygous mutation in the methylenetetrahydrofolate reductase gene C677T, heterozygous factor-V Leiden mutation, and active protein C resistance were identified in the patient. The patient was lost because of a recurring episode of pulmonary embolism on the 86th day of hospitalization. We present this case to highlight the need for investigating hereditary thrombosis risk factors in diabetic patients in whom thromboembolism develops. Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.
Databáze: OpenAIRE